LAB.00041 Machine Learning Derived Probability Score for Rapid Kidney Function Decline

This policy addresses machine learning–derived probability scores (e.g., KidneyIntelX) that combine blood biomarkers and clinical/EHR data to predict rapid kidney function decline in individuals with chronic kidney disease, including those with diabetic kidney disease. Anthem considers these tests investigational/experimental and not medically necessary; therefore, they are not covered for any indication. There are no covered indications or exceptions—use for risk prediction or stratification is non-covered across all settings.

"Use of a machine learning derived probability score (e."

Sign up to see full coverage criteria, indications, and limitations.